About us
Coriolis Pharma - outstanding biopharmaceutical research

Coriolis Pharma is a globally operating contract research organization (CRO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines. Founded in 2008, Coriolis is the expert for early and late-stage biopharmaceutical development of liquid and lyophilized drug products, including lyophilization process development and analytical method development under R&D and GMP. Non-GMP manufacturing services for a wide range of products complete the service portfolio. We have supported the successful development of many drug products and our scientists are eager to apply their experience to your project.
Our mission
Our motivation is to enable the development of innovative drugs by performing outstanding biopharmaceutical research to improve the quality of life for humankind.
Our vision
We enable innovative therapies by revolutionizing formulation development.
We revolutionize the development process of biopharmaceutical drugs by integrating innovative digital formulation approaches from drug development to commercial products. We thereby enable future therapies to be made available to humankind efficiently and on time.
Our strategy
For us innovation is progress achieved by collaboration. We generate innovation by combining technologies, knowledge and experience. Formulating for us means: to find the best solution right from the start combined with speed and flexibility.
Our facts & figures
Foundation of Coriolis Pharma
Move to the IZB (Innovation and Start-Up Center for Biotechnology) in Martinsried
GMP accreditation
Biological Safety Level (BSL) 1 & 2 certification
Move to new facilities in Martinsried
Expansion into new facilities for ATMP development (up to BSL2)
Your partner with scientific excellence
From discovery phase to and beyond market approval, Coriolis provides high-quality research, development, and analytical services. Our strategy is to generate innovation by combining technologies, knowledge, and experience. In collaborative partnership with our clients, we develop innovative drugs to improve the quality of life for humankind.
Let's talk!
Click on a topic to contact our experts
Dr. Matthias Lucke
Business Development Manager
Phone: +49 89 41 77 60 – 253
Mail: matthias.lucke@coriolis-pharma.com

Dr. Eva Keilhauer
Business Development Manager (Liquid Formulations)
Phone: +49 89 41 77 60 -0
Mail: eva.keilhauer@coriolis-pharma.com

Dr. Anna Gebhardt
Business Development Manager (ATMPs)
Phone: +49894177600
Mail: Anna.Gebhardt@coriolis-pharma.com

Dr. Evelyn Eggenstein
Business Development Manager (USA)
Phone: 12486796167
Mail: evelyn.eggenstein@coriolis-pharma.com

Dr. Jörg Müller
Business Development Manager
Phone: +49 89 41 77 60 – 111
Mail: joerg.mueller@coriolis-pharma.com

Dr. Anja Bürger
Business Development Manager
Phone: +49 89 41 77 60 – 259
Mail: anja.buerger@coriolis-pharma.com

Dr. Daniel Weinbuch
Business Development Manager
Phone: +49 89 41 77 60 - 149
Mail: daniel.weinbuch@coriolis-pharma.com

Dr. Evelyn Eggenstein
Business Development Manager (USA)
Phone: 12486796167
Mail: evelyn.eggenstein@coriolis-pharma.com

Dr. Cora Keil
Business Development Manager
Phone: +49 89 417 760-0
Mail: cora.keil@coriolis-pharma.com

Dr. Evelyn Eggenstein
Business Development Manager (USA)
Phone: 12486796167
Mail: evelyn.eggenstein@coriolis-pharma.com

Dominik Schwemmer
People Experience & Organizational Development Partner
Phone: +49 89 41 77 60 – 0
Mail: career@coriolis-pharma.com
Check our current job vacancies


Coriolis Pharma Research GmbH
Biopharmaceutical Research and Development Service
Fraunhoferstraße 18 b
82152 Martinsried
Germany
Phone: +49 89 41 77 60 – 0
Fax: +49 89 41 77 60 – 222
Get in touch
Service request: business.development@coriolis-pharma.com
Job request: career@coriolis-pharma.com
Media request: media@coriolis-pharma.com
Follow us